Dr. Archana Jalligampala From University of Louisville Awarded $90,000 Knights Templar Eye Foundation Grant for Retinitis Pigmentosa Research
January 12, 2024
January 12, 2024
FLOWER MOUND, Texas, Jan. 12 -- Knights Templar Eye Foundation issued the following news:
Dr. Archana Jalligampala from the University of Louisville, School of Medicine, Louisville, Kentucky was awarded a $90,000 grant to study: Therapeutic efficacy of a novel stereopure antisense oligonucleotide (ASO) - Wave1, to treat P23H autosomal dominant retinitis pigmentosa.
Humans navigate the world primarily using vision. Imagine a parent learning that their child has a disorde . . .
Dr. Archana Jalligampala from the University of Louisville, School of Medicine, Louisville, Kentucky was awarded a $90,000 grant to study: Therapeutic efficacy of a novel stereopure antisense oligonucleotide (ASO) - Wave1, to treat P23H autosomal dominant retinitis pigmentosa.
Humans navigate the world primarily using vision. Imagine a parent learning that their child has a disorde . . .